KNOXVILLE, Tenn.--(BUSINESS WIRE)--The Center for Biomedical Research is partnering with the world’s newest proton therapy center as part of a clinical meta-registry for clinical outcomes and long-term follow-up of cancer patients receiving proton therapy.
Ackerman Cancer Center has joined the registry study developed and managed by the Center for Biomedical Research in collaboration with the Provision Center for Proton Therapy. The registry study meets all guidelines as outlined in the AHRQ’s guidelines for Registries for Evaluating Patient Outcomes.
Help employers find you! Check out all the jobs and post your resume.
